Company: UHS
Filing Date: 2025-02-26
Form Type: 10-K
Source: 0000950170-25-027785
Chunk: 158

Company: UNIVERSAL HEALTH SERVICES INC
Filing Date: 2025-02-26
Form: 10-K
Item: Item 1B
Chunk 158
---
 September, 2024, and replaced with a new $1.2 billion tranche A term loan facility; (ii) $366 million related to our revolving credit facility, and; (iii) $15 million related to other debt facilities;

•generated $2.210 billion of proceeds from additional borrowings as follows: (i) $1.200 billion related to our new tranche A term loan facility, as mentioned above; (ii) generated approximately $500 million of net proceeds (before expenses) related to the public offering, in September, 2024, of 4.625% senior secured notes due in 2029; (iii) generated approximately $498 million of net proceeds (before expenses) related to the public offering, in September, 2024, of 5.050% senior secured notes due in 2034, and; (iv) $12 million of proceeds related to other debt facilities;

•spent $671 million to repurchase shares of our Class B Common Stock in connection with: (i) open market purchases pursuant to our stock repurchase program ($599 million), and; (ii) income tax withholding obligations related to stock-based compensation programs ($72 million);

•spent $53 million to pay quarterly cash dividends of $.20 per share; 

•generated $15 million from the issuance of shares of our Class B Common Stock pursuant to the terms of employee stock purchase plans;

•received $13 million from the sale of ownership interests to minority members;

•spent $13 million to pay financing costs, and;

•spent $7 million to pay profit distributions related to noncontrolling interests in majority owned businesses.

2023:

The $494 million of net cash used in financing activities during 2023 consisted of the following:

•generated $185 million of proceeds from additional borrowings pursuant to our revolving credit facility;

•spent $547 million to repurchase shares of our Class B Common Stock in connection with: (i) open market purchases pursuant to our stock repurchase program ($524 million), and; (ii) income tax withholding obligations related to stock-based compensation programs ($23 million);

•spent $85 million on net repayment of debt as follows: (i) $79 million related to our tranche A term loan facility, and; (ii) $6 million related to other debt facilities; 

69

•spent $55 million to pay quarterly cash dividends of $.20 per share; 

•generated $14 million from the issuance of shares of our Class B Common Stock pursuant